Bicara Therapeutics Inc. 4

Insider Christy J. Oliger received a stock option award for 38,950 shares of Bicara Therapeutics Inc. common stock at a $26.88 exercise price.

On July 28, 2026, Christy J. Oliger, an insider of Bicara Therapeutics Inc., was granted a stock option covering 38,950 shares of Common Stock at an exercise price of $26.88 per share. This award is structured to vest over time, with one-third of the option becoming exercisable on July 28, 2027 and the remaining two-thirds vesting in 24 equal monthly installments thereafter, contingent on her continued service to the company. Following this grant, Oliger holds derivative securities representing 38,950 shares, with an estimated notional value of approximately $1,047,576 based on the option exercise price; this appears to be a routine equity compensation award rather than an open-market purchase or sale.

Filing Facts

CIK

2023658

Ticker

BCAX

Form

4

Source Type

fda

Accession

0001470831-26-000737

Alert Tier

6